ARE ALL STAGE-III CANCERS OF THE OVARY REALLY CANCERS OF THE OVARY

  • 1 January 1981
    • journal article
    • research article
    • Vol. 4  (2) , 219-220
Abstract
A recent chemotherapy trial in ovarian carcinoma raised questions about the diagnosis and staging of this disease. Review of the protocol records indicated that all 45 patients had a histologic or cytologic diagnosis of carcinoma. However, in 3 cases it was not stated how the primary site was determined. Another 4 cases were not explored, while 8 others were explored, but the primary was not identified; the pathologic material was consistent with ovarian adenocarcinoma. Thus, 1/3 (15) of the patients had not had their primary adequately demonstrated. Published studies of advanced ovarian cancer typically refer to the FIGO [International Federation of Gynecology and Obstetrics] staging system and imply that the primary lesion was actually identified, but review of the operative report and slide review of the primary lesion are not always described or required. Casually diagnosed cases should be labeled as such and evaluated separately.

This publication has 0 references indexed in Scilit: